Literature DB >> 2668194

Treponema pallidum-immobilizing antibodies in guinea pig experimental syphilis.

K Wicher1, J N Miller, A W Urquhart, V Wicher.   

Abstract

Treponema pallidum-immobilizing (TPI) antibodies were examined in intradermally infected inbred strain 13 and adoptively immune inbred strain 2 guinea pigs. Both strains of animals produced TPI antibodies at or after 90 days of infection. TPI antibodies were not associated with the protective mechanism(s) operative after challenge in adoptively immune animals.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2668194      PMCID： PMC313544          DOI： 10.1128/iai.57.9.2900-2902.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  [Treponemic dispersion in experimental syphilis in guinea-pigs].

Authors:  P GASTINEL; A VAISMAN
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1955 Sep-Oct

2.  The relationship of treponemal immobilizing antibody to immunity in syphilis.

Authors:  T B TURNER; R A NELSON
Journal:  Trans Assoc Am Physicians       Date:  1950

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation.

Authors:  J N Miller
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Correlation of treponemicidal activity in normal human serum with the presence of IgG antibody directed against polypeptides of Treponema phagedenis biotype Reiter and Treponema pallidum, Nichols strain.

Authors:  D R Blanco; J D Radolf; M A Lovett; J N Miller
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

7.  Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen.

Authors:  T E Fehniger; A M Walfield; T M Cunningham; J D Radolf; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Adoptive transfer of immunity to Treponema pallidum Nichols infection in inbred strain 2 and C4D guinea pigs.

Authors:  V Wicher; K Wicher; A Jakubowski; S M Nakeeb
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

Review 9.  Experimental syphilis in guinea pig.

Authors:  K Wicher; V Wicher
Journal:  Crit Rev Microbiol       Date:  1989       Impact factor: 7.624

10.  Differences in susceptibility to infection with Treponema pallidum (Nichols) between five strains of guinea pig.

Authors:  K Wicher; V Wicher; R F Gruhn
Journal:  Genitourin Med       Date:  1985-02
View more
  3 in total

Review 1.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 2.  Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.

Authors:  S J Norris
Journal:  Microbiol Rev       Date:  1993-09

Review 3.  The wide utility of rabbits as models of human diseases.

Authors:  Pedro J Esteves; Joana Abrantes; Hanna-Mari Baldauf; Lbachir BenMohamed; Yuxing Chen; Neil Christensen; Javier González-Gallego; Lorenzo Giacani; Jiafen Hu; Gilla Kaplan; Oliver T Keppler; Katherine L Knight; Xiang-Peng Kong; Dennis K Lanning; Jacques Le Pendu; Ana Lemos de Matos; Jia Liu; Shuying Liu; Ana M Lopes; Shan Lu; Sheila Lukehart; Yukari C Manabe; Fabiana Neves; Grant McFadden; Ruimin Pan; Xuwen Peng; Patricia de Sousa-Pereira; Ana Pinheiro; Masmudur Rahman; Natalie Ruvoën-Clouet; Selvakumar Subbian; Maria Jesús Tuñón; Wessel van der Loo; Michael Vaine; Laura E Via; Shixia Wang; Rose Mage
Journal:  Exp Mol Med       Date:  2018-05-22       Impact factor: 8.718
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.